BeiGene Ltd. (ADRs)
- BID
278
- ASK
280
- 90 Units139 Units
- 07/21, 17:11:45 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
6.25%
Market Cap
-
P/E Ratio
119.81
Dividend Yield
0.00 %
Earnings per Share
2.25 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 278 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 05:04:22 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 282 | 272 |
| PREV. DAY'S PRICE | 272 | (07/20) |
| CHANGE DAY BEFORE | +6.00 | 2.21 % |
| 52 WEEK HIGH / LOW | 328 (11/13) | 220 (06/15) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -7.81 | -5.66 | 2.25 | 5.58 | 8.50 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | - | 119.81 | 48.91 | 32.08 |
PRICE - BOOK RATIO | 5.33 | 5.92 | 7.72 | - | - |
PRICE - SALES RATIO | 7.66 | 5.10 | 6.43 | - | - |
PRICE - CASH FLOW RATIO | - | - | 30.49 | - | - |
Master Data
| WKN | A1437N |
| ISIN | US07725L1026 |
| SYMBOL | 49BA |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | BEIGENE LTD SP.ADR |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 2.26 % | 15.25 % | 0.74 % | -4.23 % | 6.25 % | 59.06 % | 2.26 % | 5.43 % |
| HIGH | 280.00 | 280.00 | 280.00 | 314.00 | 328.00 | 328.00 | 386.00 | 314.00 |
| LOW | 264.00 | 228.00 | 220.00 | 220.00 | 220.00 | 117.00 | 115.00 | 220.00 |
Dividende
pro Aktie
BEIGENE LTD SP.ADR does not deliver dividend information
Company profile
BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.
Structured products for BeiGene Ltd. (ADRs)
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.